RecruitingNot ApplicableNCT07066761

Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious)

Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Lateral Suspension (LatGYNious)


Sponsor

A.M.I. Agency for Medical Innovations GmbH

Enrollment

85 participants

Start Date

Jul 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the clinical investigation is to verify that the investigational device (LatGYNious) is appropriate to significantly improve the pelvic organ prolapse in patients.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Laparoscopic lateral suspension with surgical mesh (LatGYNious) for people with genital prolapse, laparoscopic surgery, and other related conditions. The study is currently recruiting participants at 5 locations. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELaparoscopic lateral suspension with surgical mesh (LatGYNious)

Laparoscopic lateral suspension with LatGYNious (with uterus preservation or after hysterectomy)


Locations(5)

BZK St. Johann in Tirol

Sankt Johann in Tirol, Tyrol, Austria

LKH Feldkirch, Gynäkologie und Geburtshilfe

Feldkirch, Austria

Universitätsklinik Brandenburg a.d. Havel, Klinik für Frauenheilkunde und Geburtshilfe

Brandenburg, Germany

Krankenhaus St. Joseph-Stift Bremen

Bremen, Germany

Medizincampus Bodensee - Klinik Tettnang

Tettnang, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07066761


Related Trials